Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
TG2-mediated modification of the GST tag caused aggregate formation but did not affect its glutathione binding affinity
This triple-action mechanism distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1/GIP agonist)
It is available mainly through research channels, and its use is strictly for laboratory and scientific investigation, not for human consumption
the similar GIP/GLP-1 medication, tirzepatide (Mounjaro, Zepbound)
US$ 22.99
US$ 26.98
US$ 26.63
US$ 29.90
US$ 25.47
